Gl. Kukielka et al., REGULATION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN ISCHEMIC AND REPERFUSED CANINE MYOCARDIUM, The Journal of clinical investigation, 92(3), 1993, pp. 1504-1516
Previous studies in vitro have shown an important role for intercellul
ar adhesion molecule-1 (ICAM-1) in adherence interactions of canine ne
utrophils with canine jugular vein endothelial cells and in cytotoxici
ty of canine neutrophils for adult cardiac myocytes. To evaluate the r
egulation of ICAM-1 in myocardial inflammation and its role in the pat
hogenesis of myocardial ischemia and reperfusion, a series of in vivo
and ex vivo studies were performed in canine animals. Systemic adminis
tration of LPS elicited ICAM-1 mRNA in several tissues, including myoc
ardium, which demonstrated increasing ICAM-1 staining on intercalated
discs of cardiac myocytes. In ischemia and reperfusion protocols: (a)
ICAM-1 mRNA was found in ischemic segments within 1 h of reperfusion a
nd in both ischemic and normally perfused segments by 24 h of reperfus
ion; (b) expression of ICAM-1 was detected in cardiac myocytes in the
ischemic region by 6 h of reperfusion; increased expression was seen t
hereafter as a function of time; (c) postischemic (but not preischemic
) cardiac lymph collected at intervals from 1 to 24 h after reperfusio
n elicited ICAM-1 mRNA, ICAM-1 expression, and ICAM-1-dependent neutro
phil adhesion in canine jugular vein endothelial cells and in cardiac
myocytes with peak cytokine activity seen by 1 h; (d) extravascular lo
calization of neutrophils was detected in ischemic areas only, and was
associated with endothelium bearing high levels of ICAM-1 within 1 h
of reperfusion; infiltration increased thereafter in association with
increasing levels of ICAM-1 mRNA in myocardial segments and increasing
levels of ICAM-1 expression on cardiac myocytes. These findings provi
de the first direct evidence for inflammatory regulation of ICAM-1 in
ischemic and reperfused canine myocardium. They support the hypothesis
that ICAM-1 participates in neutrophil-mediated myocardial damage.